Remdesivir authorized as COVID-19 treatment in Canada, but it remains in short supply

featured image

Health Canada has actually approved remdesivir as the country’s first COVID-19 treatment, however there are concerns about the drug’s accessibility after the U.S. purchased up most of the manufacturer’s supply.

See The National survive on YouTube Sunday-Friday at 9 p.m. ET

Register for The National:
https://www.youtube.com/user/CBCTheNational?sub_confirmation=1

Connect with The National online:.
Facebook| https://www.facebook.com/thenational
Twitter| https://twitter.com/CBCTheNational
Instagram| https://www.instagram.com/cbcthenational

More from CBC News| https://www.cbc.ca/news

The National is CBC’s flagship nighttime news program, featuring the day’s top stories with thorough and original journalism, with hosts Adrienne Arsenault and Andrew Chang in Toronto, Ian Hanomansing in Vancouver and the CBC’s chief political correspondent, Rosemary Barton in Ottawa.

https://covid19globalcases.com/remdesivir-authorized-as-covid-19-treatment-in-canada-but-it-remains-in-short-supply/

Comments